rs17856705

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_178452.6(DNAAF1):​c.1178A>G​(p.Lys393Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,613,638 control chromosomes in the GnomAD database, including 158,604 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11560 hom., cov: 33)
Exomes 𝑓: 0.44 ( 147044 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.0210

Publications

27 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.163822E-4).
BP6
Variant 16-84170006-A-G is Benign according to our data. Variant chr16-84170006-A-G is described in ClinVar as Benign. ClinVar VariationId is 226572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.456 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.1178A>G p.Lys393Arg missense_variant Exon 8 of 12 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.1178A>G p.Lys393Arg missense_variant Exon 8 of 12 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1

Frequencies

GnomAD3 genomes
AF:
0.377
AC:
57381
AN:
152070
Hom.:
11549
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.227
Gnomad AMI
AF:
0.487
Gnomad AMR
AF:
0.404
Gnomad ASJ
AF:
0.386
Gnomad EAS
AF:
0.332
Gnomad SAS
AF:
0.304
Gnomad FIN
AF:
0.444
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.460
Gnomad OTH
AF:
0.368
GnomAD2 exomes
AF:
0.402
AC:
101023
AN:
251180
AF XY:
0.402
show subpopulations
Gnomad AFR exome
AF:
0.218
Gnomad AMR exome
AF:
0.411
Gnomad ASJ exome
AF:
0.381
Gnomad EAS exome
AF:
0.342
Gnomad FIN exome
AF:
0.441
Gnomad NFE exome
AF:
0.456
Gnomad OTH exome
AF:
0.408
GnomAD4 exome
AF:
0.444
AC:
649027
AN:
1461448
Hom.:
147044
Cov.:
88
AF XY:
0.439
AC XY:
319329
AN XY:
727012
show subpopulations
African (AFR)
AF:
0.217
AC:
7271
AN:
33470
American (AMR)
AF:
0.411
AC:
18380
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.383
AC:
10020
AN:
26136
East Asian (EAS)
AF:
0.332
AC:
13184
AN:
39698
South Asian (SAS)
AF:
0.306
AC:
26410
AN:
86242
European-Finnish (FIN)
AF:
0.443
AC:
23670
AN:
53410
Middle Eastern (MID)
AF:
0.353
AC:
1933
AN:
5470
European-Non Finnish (NFE)
AF:
0.471
AC:
523183
AN:
1111956
Other (OTH)
AF:
0.414
AC:
24976
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
26211
52421
78632
104842
131053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15450
30900
46350
61800
77250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.377
AC:
57415
AN:
152190
Hom.:
11560
Cov.:
33
AF XY:
0.375
AC XY:
27891
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.227
AC:
9444
AN:
41556
American (AMR)
AF:
0.405
AC:
6194
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.386
AC:
1338
AN:
3470
East Asian (EAS)
AF:
0.332
AC:
1716
AN:
5164
South Asian (SAS)
AF:
0.304
AC:
1468
AN:
4828
European-Finnish (FIN)
AF:
0.444
AC:
4702
AN:
10592
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.460
AC:
31251
AN:
67968
Other (OTH)
AF:
0.364
AC:
769
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1850
3699
5549
7398
9248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.421
Hom.:
42767
Bravo
AF:
0.369
TwinsUK
AF:
0.476
AC:
1764
ALSPAC
AF:
0.473
AC:
1822
ESP6500AA
AF:
0.225
AC:
991
ESP6500EA
AF:
0.457
AC:
3932
ExAC
AF:
0.400
AC:
48528
Asia WGS
AF:
0.286
AC:
994
AN:
3478
EpiCase
AF:
0.442
EpiControl
AF:
0.445

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 05, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Lys393Arg in exon 8 of DNAAF1: This variant is not expected to have clinical s ignificance it has been identified in 45% (30157/66644) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs17856705). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Dec 10, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 13 Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.79
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
1.1
DANN
Benign
0.67
DEOGEN2
Benign
0.0066
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.044
N
LIST_S2
Benign
0.41
T
MetaRNN
Benign
0.00012
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.1
L
PhyloP100
-0.021
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.48
N
REVEL
Benign
0.055
Sift
Benign
0.22
T
Sift4G
Benign
0.44
T
Polyphen
0.0010
B
Vest4
0.025
MPC
0.019
ClinPred
0.0016
T
GERP RS
0.13
Varity_R
0.025
gMVP
0.055
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17856705; hg19: chr16-84203612; COSMIC: COSV57576724; COSMIC: COSV57576724; API